Clinical remission after stopping infliximab in Crohn's Disease: Is all that glitters true gold?

Gastroenterology

Volumn 142, Issue 5, 2012, Pages

  Sorrentino, Dario ^a,b   Radford Smith, Graham ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF UDINE   (Italy)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; C REACTIVE PROTEIN; CORTICOSTEROID; INFLIXIMAB; TUMOR NECROSIS FACTOR INHIBITOR;

CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ACTIVITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE RESECTION; LETTER; LEUKOCYTE COUNT; MALE; PATIENT CARE; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; REMISSION; SAMPLE SIZE; TREATMENT RESPONSE;

EID: 84860207637     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.02.054     Document Type: Letter

References (8)

1. E. Louis et al. Gastroenterology 142 2012 63 70
2. P. De Cruz et al. Inflamm Bowel Dis 2011 Aug 9 [Epub ahead of print]
3. M.F. Picco, T.M. Bayless Am J Gastroenterol 98 2003 363 368
4. D.P. van Asseldonk et al. Dig Liver Dis 43 2011 270 276
5. E.A. Maser et al. Clin Gastroenterol Hepatol 4 2006 1248 1254
6. F. Baert et al. Gastroenterology 138 2010 463 468
7. C. Ha, A. Kornbluth Curr Gastroenterol Rep 12 2010 471 478
8. D. Sorrentino et al. Clin Gastroenterol Hepatol 8 2010 591 599